Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is desi... Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol. Show more
STOUGHTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of...
– Generated Record Q3’24 Net Revenue of $159.3 Million, Up 17% Year-over-Year, Driven by Record Belbuca® Revenue of $53.2 Million and Record Xtampza® ER Revenue of $49.5 Million – – Achieved...
STOUGHTON, Mass., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of...
STOUGHTON, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.6 | -1.96335078534 | 30.56 | 30.95 | 28.97 | 523823 | 29.74843207 | CS |
| 4 | -4.51 | -13.0838410212 | 34.47 | 35.95 | 28.97 | 474723 | 31.86968302 | CS |
| 12 | -8.65 | -22.4035224035 | 38.61 | 42.2873 | 28.97 | 404932 | 35.68452074 | CS |
| 26 | -4.56 | -13.2097334878 | 34.52 | 42.2873 | 28.97 | 443074 | 34.69928737 | CS |
| 52 | 4.27 | 16.621253406 | 25.69 | 42.2873 | 25.16 | 443107 | 34.35143536 | CS |
| 156 | 10.94 | 57.5184016824 | 19.02 | 42.2873 | 14.04 | 366620 | 26.62335511 | CS |
| 260 | 10.72 | 55.7172557173 | 19.24 | 42.2873 | 13 | 382520 | 24.29786624 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
